AllianceBernstein
BHVN

AllianceBernstein’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

AllianceBernstein’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-314,412
Closed -$47.5M – 3393
2022
Q3 		$47.5M Sell
314,412
-37,465
-11% -$5.55M 0.02% 547
2022
Q2 		$51.3M Sell
351,877
-291,459
-45% -$37.2M 0.02% 543
2022
Q1 		$76.3M Sell
643,336
-510,992
-44% -$63.7M 0.03% 485
2021
Q4 		$159M Buy
1,154,328
+78,494
+7% +$9.98M 0.06% 314
2021
Q3 		$149M Sell
1,075,834
-324,086
-23% -$40.5M 0.06% 307
2021
Q2 		$136M Sell
1,399,920
-56,639
-4% -$4.6M 0.05% 336
2021
Q1 		$99.6M Buy
1,456,559
+251,355
+21% +$20.3M 0.04% 405
2020
Q4 		$103M Sell
1,205,204
-243,960
-17% -$20.7M 0.05% 374
2020
Q3 		$94.2M Buy
1,449,164
+230,636
+19% +$15.1M 0.05% 342
2020
Q2 		$89.1M Sell
1,218,528
-297,282
-20% -$15.8M 0.05% 343
2020
Q1 		$51.6M Sell
1,515,810
-98,380
-6% -$4.5M 0.04% 435
2019
Q4 		$87.9M Sell
1,614,190
-296,991
-16% -$14.7M 0.05% 361
2019
Q3 		$79.7M Buy
1,911,181
+504,090
+36% +$21.3M 0.05% 372
2019
Q2 		$61.6M Sell
1,407,091
-56,018
-4% -$3.16M 0.04% 480
2019
Q1 		$75.3M Buy
1,463,109
+72,090
+5% +$3.11M 0.05% 393
2018
Q4 		$51.4M Sell
1,391,019
-193,963
-12% -$6.99M 0.04% 463
2018
Q3 		$59.5M Sell
1,584,982
-216,398
-12% -$7.96M 0.04% 456
2018
Q2 		$71.2M Buy
1,801,380
+343,353
+24% +$10.9M 0.05% 400
2018
Q1 		$37.6M Sell
1,458,027
-139,729
-9% -$4.18M 0.03% 575
2017
Q4 		$43.1M Buy
1,597,756
+733,526
+85% +$20.2M 0.03% 531
2017
Q3 		$32.3M Buy
864,230
+429,021
+99% +$13M 0.02% 618
2017
Q2 		$10.9M Buy
+435,209
New +$10M 0.01% 899

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

AllianceBernstein's BHVN Position: Q4 2022 in Review

AllianceBernstein sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 314,412 shares — an estimated $47.5M sold.

AllianceBernstein first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $159M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • AllianceBernstein reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • AllianceBernstein sold 314,412 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $47.5M.
  • AllianceBernstein first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • AllianceBernstein's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $159M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.